How Big Is the Lung Cancer Treatment Market | Segments & Forecast 2032

Q: What is the projected market size of the lung cancer treatment market?

The lung cancer treatment market is forecast to exceed USD 66.1 billion by 2032 due to rising incidence and the adoption of advanced therapeutic approaches.

Q: Who are the major players in the lung cancer treatment market?

Merck, Bristol Myers Squibb, AstraZeneca, Roche, Pfizer, and Novartis lead the lung cancer treatment market with strong oncology pipelines.

Q: What innovations are shaping the lung cancer treatment market?

Innovations such as immunotherapy, personalized medicine, and resistance-mutation targeting drugs are transforming the lung cancer treatment market.

Q: What healthcare shifts are influencing the lung cancer treatment market?

Increased funding, insurance coverage expansion, and patient-centric care models are impacting the lung cancer treatment market's accessibility and reach.

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA6961

Publication Date: Jul 2025

How Big Is the Lung Cancer Treatment Market?

According to 6Wresearch internal database and industry insights, the lung cancer treatment market was valued at USD 35.8 billion in 2025 and is projected to surpass USD 66.1 billion by 2032, expanding at a CAGR of 9.1%.

The growth is being fueled by more lung cancer cases, quicker approvals of immunotherapy and targeted therapies, and also more government initiatives toward public health infrastructure based on oncology. Enhanced insurance coverage and raising awareness among patients also stimulate the uptake of treatment.

Growth Factors of the Lung Cancer Treatment Market

Rising lung cancer burden is boosting treatment demand
Targeted therapy and immunotherapy adoption is increasing
Clinical trials and R&D investments are expanding globally
Public and private healthcare expenditure is steadily rising
Precision medicine is enabling individualized treatment plans
Better accessibility to treatment in developing countries is improving outcomes

Lung Cancer Treatment Market Trends

The lung cancer treatment market has seen dramatic changes as the bulk of the treatment decision is being placed on immuno-oncology treatments with PD-1 and PD-L1 inhibitors being the new front-line treatments. The use of companion diagnostics is becoming increasingly important in informing treatment selection. Some hospitals and cancer treatment centers are integrating combination regimens in an effort to improve survival in both NSCLC and SCLC forms.

Emerging Developments in the Lung Cancer Treatment Market

New developments in the Lung Cancer Treatment Market include bispecific antibodies, CAR-T therapies for solid tumors, and development of drugs for targeting resistance with EGFR and ALK mutations. There are decentralized care models and home delivery of drugs for advanced stage patients, which have enhanced comfort and adherence.